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Salicylaldehyde thiosemicarbazone copper
complexes: impact of hybridization with estrone
on cytotoxicity, solution stability and redox
activity†
Tatsiana V. Petrasheuskaya, ab Ma´rton A. Kiss, c Orsolya Do¨mo¨to¨r,ab
Tama´s Holczbauer, de No´ra V. May, d Gabriella Spengler,bf Annama´ria Kincses,f
Ana Cˇipak Gasˇparovic´,g E´va Frankc and E´va A. Enyedy *ab
An estrone–salicylaldehyde thiosemicarbazone hybrid (estrone–TSC) containing integrated domains was
designed and synthesized with excellent yield via the condensation reaction of thiosemicarbazide and
2-formyl-estrone under optimized microwave reaction conditions. A structurally related bicyclic
derivative (thn-TSC) starting from 5,6,7,8-tetrahydro-1-naphtol (th-1-n) was also prepared in addition to
their copper(II) complexes. The ligands have somewhat higher pKa values determined for the
deprotonation of the hydroxyl group by UV-visible spectrophotometric and fluorometric titrations than
the reference compound salicylaldehyde thiosemicarbazone (STSC), and are neutral at physiological pH.
The novel conjugates are more lipophilic and possess higher membrane permeability than STSC based
on the n-octanol/water partitioning and the parallel artificial membrane permeability assays, respectively.
The isolated [Cu(estrone–TSCH2)] and [Cu(thn-TSCH2)] complexes were characterized by ESI-MS,
UV-visible and EPR spectroscopy and a detailed solution study was performed to reveal their stoichio-
metry, stability and reduction by glutathione. The crystal structure of the ligand thn-TSC and its complex
[Cu(thn-TSCH1)Cl] was studied by single crystal X-ray diffraction method. The complexes are fairly
stable at pH 7.4, the observed stability order is STSC o thn-TSC o estrone–TSC, and are able to oxidize
glutathione readily. The novel ligands thn-TSC and estrone–TSC were found to be only moderately
cytotoxic against several human cancer cell lines; however rather low IC50 values were measured in the
hormone-responsive MCF-7 breast cancer cell lines (thn-TSC: 3.7 mM, estrone–TSC: 6.4 mM). The
copper(II) complexes exhibited high cytotoxicity (IC50 o 0.3–2 mM) and were considerably more cyto-
toxic than the respective ligands. Low level of reactive oxygen species was measured and a weak GSH
depletion was observed for the complexes of thn-TSC and estrone–TSC in SUM159 breast cancer cells,
thus their mechanism of action might be related to the induction of oxidative stress.
Introduction
Thiosemicarbazones (TSCs) have been investigated for their
versatile pharmacological activity including anticancer proper-
ties for many decades.1–3 To date, 3-aminopyridine-2-carbox-
aldehyde thiosemicarbazone (Triapine) is the most prominent
representative of the compound class of a-N-heterocyclic TSCs
has been already tested in more than 30 clinical phase I and II
trials4,5 and currently is involved in a Triapine–cisplatin–
radiation combination therapy in a phase III trial.6 According
to these studies, Triapine has some adverse effects (e.g. methe-
moglobinemia) and unfavorable pharmacokinetic profile, such
as short plasma half-life arising from rapid metabolism and
excretion7 which leads to the inefficiency of the active agent
against solid tumors.8 Therefore, development of novel TSCs in
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order to increase the drug efficacy and decrease the side effects
is of high research interest. Notably, di-2-pyridylketone 4-cyclo-
hexyl-4-methyl-3-thiosemicarbazone (DpC) and 4-(2-pyridinyl)-2-
(6,7-dihydro-8(5H)-quinolinylidene)-hydrazide (COTI-2) are
currently undergoing phase I evaluation for treatment of
advanced solid tumors and gynecologic malignancies,
respectively.9,10 The iron containing enzyme ribonucleotide
reductase is considered as the main target for Triapine and
related TSCs due to their prominent iron binding ability.11
On the other hand, the role of the formation of intracellular
copper(II) complexes that can be involved in redox cycling in
the presence of reducing agents leading to the production of
reactive oxygen species (ROS) is also discussed for certain
subclasses of TSCs (mainly in case of N-terminally disubsti-
tuted a-N-pyridyl TSCs).12,13
Salicylaldehyde TSC (STSC, Chart 1) and its derivatives were
also reported to form high stability complexes with transition
metal ions in solution.14 STSC-based compounds generally
exhibit lower cytotoxic activity in human cancer cells in
comparison to a-N-pyridyl TSCs, although their copper(II)
complexes are often much more cytotoxic than the corres-
ponding ligands most probably due to their redox properties.15–17
The antiproliferative activity and the pharmacokinetic proper-
ties of STSC and its copper(II) complexes can be tuned by
e.g. the attachment of electron-donating substituents18,19 or
via various conjugations.20 The sterane backbone is considered
as a potential site-directing molecular unit and its conjugation
to bidentate TSCs containing (N,S) donor set was reported by
Huang et al. to yield efficient anticancer ligands and metal
complexes.21,22 Copper(II) and platinum(II) complexes of
sterane–TSC hybrid molecules were developed via the conden-
sation of the carbonyl group of estrone and pregnenolone with
thiosemicarbazide.21,22 These steroidal copper(II) complexes
exhibited good in vitro cytotoxic activity against Bel-7404 (liver
carcinoma) and HeLa (cervical carcinoma) human cancer cell
lines.22 Structurally modified cytotoxic and cytostatic steroids
are highly relevant as lead compounds for anticancer drug
discovery.23–25 A number of steroidal complexes connected to a
platinum(II) pharmacophore had also been designed and synthe-
sized in addition to the evaluation of their antiproliferative
activities.26–29 Their most important representative is VP-128,
which is a cisplatin-type complex conjugated to the clinically
approved drug 17b-estradiol.29 This platinum(II) complex
showed excellent in vitro efficiency toward hormone-dependent
breast cancer cells and higher in vivo antitumor activity
against breast cancer xenografts in nude mice compared with
cisplatin.29
Notably, the primary hormonal activity of the steroidal
carrier is undesirable, thus it should be eliminated. Since
C-2 aldehyde of estrogens has been demonstrated to display
reduced or no estrogenic activity,30 they can be suitable pre-
cursors for the synthesis of TSC–estrone hybrid molecules.
Moreover, numerous 2-substituted estrone derivatives have been
reported to display significant antitumor activity with negligible
hormonal effect.24 In this work we developed a tridentate
estrone–STSC hybrid ligand (estrone–TSC, Chart 1) and a
simpler bicyclic derivative as a structural model (thn-TSC,
Chart 1) in addition to their copper(II) complexes. The solution
behavior of the ligands as well as the solution stability and redox
properties of the complexes were investigated by UV-visible
(UV-vis) spectrophotometry. The ligand thn-TSC and its
copper(II) complex [Cu(thn-TSCH1)Cl] could be crystallized
and the molecular structures and secondary interactions have
been studied by single crystal X-ray diffraction. The anticancer
activity of the free ligands and their copper(II) complexes was
tested against a series of human cancer cell lines via cytotoxicity
assays, furthermore ROS production, catalase activity and
L-glutathione (GSH) levels were also monitored.
Results and discussion
Synthesis of thn-TSC and estrone–TSC
STSC is a commercially available compound, while estrone–TSC
and thn-TSC were developed in this work using an ortho-
formylation reaction of estrone and the related bicyclic
compounds (th-1-n, th-2-n) as the first step of the synthesis.
The classical formylating procedures of phenol derivatives
(e.g. Gattermann–Koch synthesis, Reimer–Tiemann reaction
and Vilsmeier–Haack formylation or Duff, Casnati and
Casiraghi reactions)31,32 suffer to a greater or lesser extent from
serious drawbacks, such as the necessity of strongly toxic
reagents, harsh reaction conditions or lack of regiocontrol
leading to the aldehydes in low to moderate yields. An excep-
tion is the regioselective ortho-formylation of phenols using
MgCl2, triethylamine (TEA) and paraformaldehyde (PFA) in
refluxing tetrahydrofuran (THF), providing high yields of
salicylaldehydes.33 The method has also been applied for the
formylation of estrone to afford excellent overall yield of
regioisomeric aldehydes in a ratio of 9 : 1, with high preference
for the 2-isomer over the 4-isomer.34 In this work the ortho-
formylation of estrone was carried out by the method of
Hofsløkken and Skattebøl33 (Scheme 1), but both the overall
yield and selectivity were found to be lower than that previously
Chart 1 Chemical structures of the investigated compounds: salicyl-
aldehyde thiosemicarbazone (STSC), 2-((1-hydroxy-5,6,7,8-tetrahydro-
naphthalen-2-yl)methylene)hydrazine-1-carbothioamide (thn-TSC) and
2-((3-hydroxy-estra-1,3,5(10)-triene-2-yl)methylene)hydrazine-1-carbo-
thioamide (estrone–TSC) in their neutral forms (HL).
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reported by Akselsen et al.34 Moreover, the regioisomers (1 and 2)
could only be separated by repeated column chromatography due
to their similar polarities. Analogous transformation of th-2-n,
structurally related to estrone, resulted in an inseparable mixture
of regioisomers (3 and 4) in a comparable ratio, although in a
higher overall yield. Therefore, compounds 3 and 4 were not used
for further transformations. On the other hand, formylation of
th-1-n afforded a single product (5) in good yield.
As a continuation, the successfully separated 2-formyl-
estrone (1) and 1-hydroxy-5,6,7,8-tetrahydronaphthalene-2-
carbaldehyde (5) were subjected to condensation reactions
with thiosemicarbazide in ethanol (EtOH) under microwave
(MW)-irradiation (Scheme 2) in the presence of a catalytic
amount of acetic acid.
The transformations occurred at 80 1C within 5 min, and the
corresponding thiosemicarbazones (estrone–TSC and thn-TSC,
Chart 1) were obtained in good-to-excellent yields after purifi-
cation by column chromatography. The novel tridentate pro-
ducts were considered to form as (E) configurational isomers in
dimethyl sulfoxide (DMSO) and proved to be quite stable due to
the extended conjugation. The structures of all synthesized
compounds were confirmed by 1H and 13C NMRmeasurements
(see Experimental section). The structure of thn-TSC was also
verified by single crystal X-ray crystallography (vide infra).
Solution phase characterization of the salicylaldehyde
thiosemicarbazone ligands
The studied compounds have limited water solubility that
hindered the use of pH-potentiometry; therefore the proton
dissociation processes of estrone–TSC and thn-TSC (Chart 1)
were primarily studied by UV-vis spectrophotometry at low
ligand concentration (55 mM) in a 30% (v/v) DMSO/H2O solvent
mixture. The same medium was used for the reference com-
pound STSC in our former work.14 STSC has been characterized
by two proton-dissociation processes and the first pKa (8.84)
was mainly attributed to the deprotonation of the phenolic OH
group, while the much higher pKa (12.57) belongs to the NH
group of the thiosemicarbazone moiety.14
UV-vis spectra recorded at various pH values for estrone–TSC
(Fig. 1a) and thn-TSC (Fig. 1b) show only a single deprotonation
process up to pH B 12, and the appearance of well-defined
isobestic points (estrone–TSC: 279 and 362 nm, thn-TSC: 272
and 350 nm) demonstrates that only two species (HL, L) are
involved in the chemical equilibrium. This deprotonation step
results in the development of a band with an increased lmax
(estrone–TSC: 374, thn-TSC: 360 nm) originating from the more
extended conjugated p-electron system in the deprotonated
form of the ligands, thus it most probably belongs to the
hydroxyl group. pKa values were calculated on the basis of
deconvolution of recorded UV-vis spectra (Table 1). The
thiosemicarbazone-NH group in estrone–TSC and thn-TSC
seems to have higher pKa compared to STSC and could not
be determined (pKa 4 12.5).
Similarly to STSC, compounds estrone–TSC and thn-TSC
also possess intrinsic fluorescence as the representative 3D
spectrum recorded for estrone–TSC shows in Fig. 2a. This
technique requires fairly low concentrations, thus fluorometric
titrations could be performed in pure aqueous solutions.
Scheme 1 Formylation of estrone and related bicyclic compounds. (Abbreviations: PFA: paraformaldehyde, th-2-n: 5,6,7,8-tetrahydronaphthalen-2-ol,
th-1-n: 5,6,7,8-tetrahydronaphthalen-1-ol, TEA: triethylamine, THF: tetrahydrofuran.)
Scheme 2 Synthesis of estrone–TSC (yield: 94%) and thn-TSC (yield:
72%).
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The emission intensity was found to be sensitive to the pH (see
the 3D spectra recorded at different pH values for estrone–TSC
in Fig. S1, ESI†), namely a significant increase in the intensity
was detected in the basic pH range upon increasing the pH
(Fig. 2b). Based on these spectral changes pKa values could be
determined in the aqueous solution for the phenolic hydroxyl
group as well (Table 1).
All the experimentally obtained and the predicted data
reveal the same trend of the pKa values, namely STSC o
estrone–TSC o thn-TSC. Most probably the increased pKa
values are due to the electron-donating effect of the neighbor-
ing cyclohexyl moieties in estrone–TSC and thn-TSC. Notably,
the pKa values are higher in the presence of DMSO compared to
those obtained in pure water as it is expected for these anionic
bases (L), which are less solvated in the DMSO/H2O mixture
making the proton dissociation more difficult. Based on the
pKa values, it can be concluded that the studied compounds are
found mostly in their neutral form at pH 7.4 in both media
(see HL%7.4 data in Table 1).
The lipophilic character and membrane permeability are
important drug properties as they strongly affect the passage
via biological membranes, since most drugs have to pass
through at least one cell membrane in order to reach their
targets. As a first step, we attempted to determine the distri-
bution coefficients (D7.4) for the compounds using the shake-
flask method in n-octanol/buffered aqueous solution at pH 7.40
(Table 1). The logD7.4 values and the predicted partition
coefficients (P, Table 1) represent strong lipophilic character
Table 1 pKa values determined by UV-vis and fluorometric titrations in 30% (v/v) DMSO/H2O and in water, respectively, fraction of HL form at pH 7.4;
logD7.4 (n-octanol/water) and effective passive permeability values (Peff) of compounds studied in addition to logP values predicted by MarvinSketch
software35 {T = 25 1C; I = 0.1 M (KCl)}
Medium Method estrone–TSC thn-TSC STSC
pKa 30% (v/v) DMSO/H2O UV-vis 9.00  0.01 9.40  0.01 8.84a
pKa H2O Fluorometry 8.94  0.01 9.15  0.01 8.74  0.01b
HL%7.4 30% (v/v) DMSO/H2O Calculated 98 99 96
HL%7.4 H2O Calculated 97 98 96
logD7.4 n-Octanol/H2O Partitioning 4+2 4+1.7 +1.59  0.05c
log P — Predicted +5.8 +2.9 +1.7
Peff (106 cm s1) H2O, pH 7.4 PAMPA n.d. 19  6 5.7  0.6
a Data taken from ref. 14. b pKa = 8.88 in ref. 14.
c logD7.4 = +1.74 in ref. 36.
Fig. 1 UV-vis absorption spectra of estrone–TSC (a) and thn-TSC
(b) pH range 2.0–11.5 in 30% (v/v) DMSO/H2O solvent mixture {cL = 55 mM;
T = 25.0 1C; I = 0.1 M (KCl); c = 1 cm}.
Fig. 2 Three dimensional fluorescence spectrum of estrone–TSC at pH
7.4 (a) and its emission spectra recorded at 390 nm excitation wavelength
in the pH range 6–12 (b) in aqueous solution {cL = 1 mM; T = 25.0 1C;
I = 0.1 M (KCl)}.
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of the compounds; however estrone–TSC and thn-TSC are so
lipophilic that only threshold limit for their logD7.4 could be
estimated since almost the whole amount of them remained in
the n-octanol phase. Then the in vitro cell-free parallel artificial
membrane permeability assay (PAMPA) was used to monitor
the ability of compounds to penetrate membranes by passive
diffusion.
UV-vis spectra recorded for the donor and acceptor phases
allowed the calculation of the effective passive permeability
coefficients (Peff, Table 1) for thn-TSC and STSC at pH 7.4
(Fig. S2a and c, ESI†), while formation of precipitate in case
of estrone–TSC under the experimental setup hindered the
determination of its Peff. Notably, data obtained for thn-TSC
is merely an estimated value due to the high level of retention
(as indicated by the significant difference between the spectra
of the original stock solution and the sum of the spectra
of the acceptor and donor phases in Fig. S2c, ESI†). Both
thn-TSC and STSC exhibit high membrane permeability
(Peff Z 1.5  106 cm s1).
Solution equilibrium of copper(II) complexes of estrone–TSC
and thn-TSC
Solution speciation of copper(II) complexes of STSC has already
been characterized in details in our previous work by the
combined use of pH-potentiometry, UV-vis spectrophotometric
titrations and electron paramagnetic resonance (EPR) spectro-
scopy.14 Measurements performed in 30% DMSO/H2O solvent
mixture revealed the formation of mono-ligand complexes
exclusively in which the ligand coordinates tridentately via
(O,N,S) donor set. Namely, in the acidic pH range a protonated
species is formed with (O,N,S) donors coordinated, in which
the non-coordinating hydrazonic nitrogen is still protonated.
The complex, in which the ligand is coordinated in the
(O,N,S) mode due to the deprotonation of the hydrazonic
nitrogen, is found in the pH range 6–9. It is important to note
that in the latter complex the negatively charged sulfur atom is
coordinated due to the thione-thiol tautomeric equilibrium.
Additionally, a mixed hydroxido species with (O,N,S)(OH)
coordination mode is present in the basic pH range.14 Based on
chemical evidences a similar binding pattern is expected in
case of the studied estrone–TSC and thn-TSC complexes. Since
estrone–TSC and thn-TSC have even worse water solubility
than, STSC UV-vis spectrophotometric titrations were applied
to determine the stability constants of the complexes in 30%
(v/v) DMSO/H2O medium. UV-vis spectra show characteristic
spectral changes upon the variation of the pH (see representa-
tive UV-vis spectra of the copper(II)–estrone–TSC system in
Fig. S3, ESI†).
Overall stability constants (log b) could be calculated by the
deconvolution of the spectra for [CuL]+, [CuLH1] and
[CuLH2]
 species (Table 2) in addition to their individual
molar spectra (Fig. 3a). Concentration distribution curves were
also computed using the stability constants determined (for the
copper(II)–estrone–TSC system see Fig. 3b).
The protonated neutral form of the ligands estrone–TSC and
thn-TSC was formulated as HL due to the single proton
dissociation step observed in the studied pH range. Therefore,
in the [CuL]+ complex, that is formed in the acidic pH range,
the ligand coordinates via replacement of one proton as an
(O,N,S) donor. The replacement of phenolic OH proton by the
copper ion and the chelate coordination of (O,N,S) donor
atoms are supported by our solid state results as crystals of
the complex of [Cu(thn-TSCH1)Cl] (Q[CuL]Cl) could be grown
and the structure could be studied by single crystal X-ray
diffraction (vide infra). Deprotonated [CuLH1] complex pre-
dominates in the pH range 5–9 and most probably is formed by
the deprotonation of the hydrazonic nitrogen, thus it contains
an (O,N,S) donor set. While [CuLH2]
 is a mixed hydroxido
species, its more correct formula is [CuLH1(OH)]. The sug-
gested structures for the complexes formed with thn-TSC are
represented in Scheme 3.
The direct comparison of the log b values of the complexes
formed with estrone–TSC, thn-TSC to those of STSC (Table 2) is
not adequate as the ligands have distinct pKa values and were
differently formulated (notably for STSC two pKa values were
determined14). On the other hand, the pKa values of the
complexes regarding the same deprotonation steps are compar-
able (e.g. pKa [CuL]
+ for estrone–TSC, thn-TSC vs. pKa [CuLH]
+
for STSC, Table 2). These pKa values show the deprotonation
of the hydrazonic-NH moiety in the slightly acidic pH range
Table 2 Overall stability constants (log b), pKa of the copper(II) complexes of estrone–TSC, thn-TSC and STSC for comparison determined by UV-vis
titrations in 30% (v/v) DMSO/H2O, and calculated pCu values at pH 7.4 using cCu = 50 mM, cligand = 50 mM. logD7.4 and Peff values determined for the
complexes. Observed rate constants (kobs) obtained for the redox reaction of the copper(II) complexes (25 mM) with GSH (1.25 mM) at pH 7.4 under
anaerobic conditions {T = 25 1C; I = 0.1 M (KCl)}
estrone–TSC thn-TSC STSC
log b [CuL]+ 13.18  0.01 13.58  0.01 logb [CuLH]+ 23.03a
log b [CuLH1] 9.44  0.01 9.35  0.01 logb [CuL] 19.02a
log b [CuLH2]
 1.26  0.04 1.15  0.02 logb [CuLH1] 8.75a
pKa [CuL]
+ 3.74 4.23 pKa [CuLH]
+ 4.01
pKa [CuLH1] 10.70 10.50 pKa [CuL] 10.27
pCu 11.53 11.05 8.77
logD7.4 42 +1.23  0.2 +0.97  0.01
Peff (106 cm s1) n.d. 5.6  0.2 1.5  0.4
kobs (min
1) 0.13  0.02 0.10  0.02 0.11  0.02
a Data taken from ref. 14 and STSC is considered as a ligand with two dissociable protons, pKa1 = 8.84; pKa2 = 12.57, unlike estrone–TSC and thn-
TSC which have only one measurable pKa value.
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(pKa B 3.74–4.23) and that of the coordinated water molecule
in the basic pH range (pKaB 10.27–10.70). Based on these data
it can be concluded that the [CuLH1] complex of estrone–TSC
is present in a wider pH range compared to the case of the other
two ligands (Fig. S4, ESI†), suggesting its superior stability. To
compare the solution stability of the complexes, thus the
copper binding ability of the studied ligands, pCu values were
also computed on the basis of the stability constants at pH 7.4
and at 50 mM concentrations of both the ligand and the metal
ion (Table 2). pCu is the negative decadic logarithm of the
unbound metal ion concentration under a chosen condition
and provides a solid basis for comparison of the complex
stabilities. The higher pCu value shows higher stability.
First of all, the obtained pCu values reflect significantly high
stability of these copper(II) complexes at pH 7.4 in all cases
(o1% decomposition), and reveal the following copper(II)
binding ability of the ligands: STSCo thn-TSCo estrone–TSC.
Synthesis and characterization of copper(II) complexes of
estrone–TSC and thn-TSC
Based on our solution equilibrium data it could be concluded
that complexes with the (O,N,S) coordination mode are
formed in a wide pH range including the neutral pH in all
cases. This type of complexes of estrone–TSC and thn-TSC
could be isolated from a DMSO/water solvent mixture at
pH B 7.4. The characterization of the synthesized complexes
([Cu(estrone–TSCH2)] and [Cu(thn-TSCH2)] (Q[CuLH1])
where the abbreviation of the ligand’s name stand for the HL
forms) was performed by EPR spectroscopy, ESI-MS and UV-vis
spectrophotometry. For comparative purposes the copper(II)
complex of STSC was also prepared and characterized by
ESI-MS and UV-vis spectrophotometry; however, the synthesis
of this complex has been already reported by several authors
previously.16,17 The ESI-MS data (collected in Experimental)
strongly support the suggested chemical structures of the
complexes. In addition, UV-vis spectra recorded in methanol
and in n-octanol (Fig. S5 and S6, ESI†) also confirm the
complex formation due to the appearance of the well-known
S - Cu charge transfer bands at 380, 395 and 406 nm for
[Cu(STSCH2)], [Cu(thn-TSCH2)] and [Cu(estrone–TSCH2)],
respectively, and the lack of the characteristic bands of the
free-ligands.
In order to confirm the coordination modes in the isolated
[Cu(thn-TSCH2)] and [Cu(estrone–TSCH2)] complexes, EPR
spectra were recorded in DMSO at room temperature (Fig. 4)
and at 77 K (Fig. S7, ESI†). First of all, no free copper(II) ions
were detected. Simulation of the EPR spectra resulted in the
Scheme 3 Suggested structures for the copper(II) complexes formed
with ligand thn-TSC (HL).
Fig. 4 Experimental (exp.) and simulated (sim.) isotropic EPR spectrum for
complexes [Cu(estrone–TSCH2)] (a) and [Cu(thn-TSCH2)] (b) in DMSO at
room temperature.
Fig. 3 Individual UV-vis absorption spectra of the different complexes
(blue lines) and ligand species (grey dashed lines) calculated for the
copper(II)–estrone–TSC system in 30% (v/v) DMSO/H2O solvent mixture
(a). Concentration distribution curves for the same system plotted together
with the absorbance changes at 390 nm (K) {cligand = 50 mM; cCu(II) =
50 mM; T = 25.0 1C; I = 0.1 M (KCl)}.
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isotropic and anisotropic EPR parameters (g and A values in
Table 3), which were compared to each other and to the
isotropic values of STSC.14 The complexes have similar Hamil-
tonian EPR parameters with well resolved hyperfine coupling of
one nitrogen donor atom, thus similar binding mode is sug-
gested. The somewhat lower g0 value measured for the estrone-
and thn-derivatives shows slightly higher ligand field in these
complexes compared to that of STSC, in agreement with the
electron donating effect of the ring substituents. Comparing
the estrone- and thn-derivatives, the only difference is due to
the slower rotational motions of the larger estrone-containing
ligand, which resulted in an increased line width.
In frozen solution (77 K) a high extent of dimerization was
detected in DMSO, especially for the estrone–TSC derivative,
therefore, the solutions were diluted with water to their half
concentration (1.5 mM). The recorded spectra revealed the
presence of both monomeric and dimeric species (Fig. S7a
and b, ESI†), e.g. in case of [Cu(estrone–TSCH2)], 76% of the
complex was still present in the dimeric form (Fig. S7c and d,
ESI†). Formation of dimers in case of the copper(II) complex of
STSC was also reported in the solid phase based on the
structure established by single crystal X-ray diffraction.16,17
Distribution coefficients (logD7.4) and effective passive per-
meability values (Peff) were also determined for the complexes
where the solubility allowed the calculations (Table 2, Fig. S2b,
d and S6, ESI†). The complexes were found to be somewhat less
lipophilic than the ligands, but their lipophilicity followed the
same trend as it was observed for the ligands: STSCo thn-TSCo
estrone–TSC. The complexes were characterized by lower Peff
values (thus somewhat lower permeability) than the ligands, most
probably due to their reduced lipophilic character.
Solid state structures of crystal thn-TSC and [Cu(thn-TSCH1)Cl]
The crystal structure of thn-TSC (I) and its copper(II) complex
[Cu(thn-TSCH1)Cl] (II) have been determined by single crystal
X-ray diffraction. Crystal I crystallized in monoclinic P21/n,
while the complex II in the orthorhombic Pbca space group.
Crystal data and structure refinement data are collected in
Table S1 (ESI†), selected bond length and angles are presented
in Table S2 (ESI†). The ORTEP representations of the two
compounds are depicted in Fig. 5. In crystal I the conformation
of the molecule is stabilized by the O1–H1O  N1 intra-
molecular hydrogen bond. The 5,6,7,8-tetrahydro-1-naphtol
ring was found in two disordered positions owing to the two
possible ring conformations. The major component was noted
with ‘A’ and the occupancy ratio was 68%. The hydrazonic
nitrogen N2 is protonated, which is consistent with the shorter
bond distances between C11–N1 1.291(3) Å. The molecules are
connected to each other via N–H  S, C–H  S or N–H  O
hydrogen bonds (Fig. S8 and Table S3, ESI†) turning slightly
out of the molecular plane. There is no considerable p  p
stacking interaction between the molecules.
In crystal [Cu(thn-TSCH1)Cl] (II) the ligand coordinates to
the copper(II) ion through deprotonated O1 and its N1 and S1
atoms and the fourth position is occupied by a chloride ion in a
square planar arrangement. The bond length is shorter for
Cu–O and Cu–N (B1.90 Å) than for Cu–S and Cu–Cl (2.26 Å).
The two chelate rings formed by Cu1–S1–C12–N2–N1 and
Cu1–N1–C11–C3–C1–O1 atoms are slightly twisted; the angle
between the two planes defined by the atoms of the ring is 8.511.
This results in a considerable deviation of S1–Cu1–O1 angle of
170.9(3)1 from the ideal 1801 of a square planar geometry (Table S2,
ESI†). In this crystal the 5,6,7,8-tetrahydro-1-naphtol ring has only
one conformation, which is equal to the conformation of the major
disorder found in the ligand crystal. The two N–H protons of the
amino group are involved in the main H-bond interactions with a
neighbouring chloride and an oxygen atom evolving columns
in the crystallographic direction ‘a’ (Fig. S9, ESI†). There is no
considerable axial coordination to the copper(II) ion and the closest
copper–copper distance is 5.63 Å.
Reduction of the copper(II) complexes of TSCs by glutathione
and ascorbic acid
The mechanism of action of the copper(II)–TSC complexes
is often related to their redox properties, namely their redox
Table 3 Isotropic and anisotropic EPR spectroscopic parameters deter-
mined for the isolated [Cu(estrone–TSCH2)] and [Cu(thn-TSCH2)] com-
plexes in DMSO and for [Cu(STSCH2)] in 30% (v/v) DMSO/H2O taken from
ref. 14
estrone–TSC thn-TSC STSCc
Isotropic parametersa
go 2.0889(3) 2.0874(1) 2.0945
Ao (G) 71.3(1) 72.8(1) 73.1
aN (G) 18.1(1) 18.1(1) 17.7
Anisotropic parametersb
gx/gy/gz 2.018/2.048/2.182 2.026/2.052/2.203 —
Ax/Ay/Az (G) 36.0/23.3/180.8 30.8/17.2/174.4 —
aNx/aNy/aNz (G) 9.5/16.4/8.5 11.6/15.6/13.0 —
a Uncertainties (SD) of the last digits are shown in parentheses. b The
experimental error were 0.001 for g, 1 G for A and aN. c Data taken
from ref. 14.
Fig. 5 Molecular structure of thn-TSC (I) (a) and [Cu(thn-TSCH1)Cl] (II)
(b) with atom numbering. Displacement parameters are drawn at 50%
probability level. Hydrogen atoms on the hydrazinic N2 nitrogen and on O1
atom involved in intramolecular hydrogen bond for crystal I are shown,
other hydrogen atoms are omitted for clarity.
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reaction with physiological reductants. GSH was reported to be
able to reduce copper(II) complexes of a-N-pyridyl TSCs resulting in
the formation of copper(I) species that can react with oxygen and
its re-oxidation generates intracellular ROS accumulation.12,13,37
Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT)
and DpC were reported to form copper(II) complexes in the
lysosomes, which can be involved in ROS production via redox
cycling leading to lysosomal membrane permeabilization and
then to apoptosis.38 In this work, the direct reaction of the
copper(II) complexes of STSC, thn-TSC and estrone–TSC with
GSH and ascorbic acid was studied spectrophotometrically. The
reaction was monitored in the wavelength range where only the
TSC and its complex absorb light in 30% (v/v) DMSO/H2O solvent
mixture under strictly anaerobic condition at pH 7.4 using the
high excess of the reducing agent (50 equiv.). The reaction with
ascorbic acid was very slow resulting in minor spectral changes,
which suggests that the studied copper(II) complexes cannot
be reduced efficiently by this reducing agent. Contrarily, the
stronger reductant, GSH, reduced these complexes. As exemplary
shown for estrone–TSC (Fig. 6) and for STSC (Fig. S10a, ESI†),
recorded spectra reveal that after mixing the reactants a fast and
significant change is observed (comparing spectra at 0 and
0.2 min), most probably as a result of the formation of a mixed
ligand complex [Cu(II)LH1(GSH)] with GSH, as it was reported
for other TSCs.37 Then the spectral changes represent the
relatively slow release of the ligand, most likely the generated
unstable copper(I) complex [Cu(I)LH1(GSH)] is decomposing,
that leads to the formation of the Cu(I)–GSH complex and the
free TSC (see spectra in Fig. S11, ESI† for clarity). The redox
reaction resulted in the complete reduction of the copper(II)
complexes under the applied conditions. Bubbling oxygen into
the solution regenerated the [Cu(II)LH1] complex (Fig. S10b,
ESI†). This finding strongly suggests the reversibility of the redox
process.
The recorded absorbance–time curves were further analyzed
at the lmax of the copper(II) complexes (Fig. 6). However, our
interpretation of these kinetic runs is considered only as a
semi-quantitative description, it can give information about the
differences in the reaction rates. Observed rate constants (kobs)
were calculated as the slope of the ln(A/A0) vs. time plots and
the calculated values are collected in Table 2. The kobs values
are very similar to each other and to the reported value for the
copper(II) complex of Triapine (0.11 min1) obtained under the
same condition, but are much higher than those obtained
for the complexes of Dp44mT (2.12  103 min1) or DpC
(2.30  103 min1).39
In vitro cytotoxicity and antioxidant properties
The colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetra-
zolium bromide (MTT) assay was applied in the doxorubicin-
sensitive Colo205, the multidrug resistant Colo320 human
colonic adenocarcinoma and the hormone-responsive MCF-
7 breast cancer cell lines to monitor the anticancer activity of
the TSC ligands and their copper(II) complexes. Notably, the
resistance of Colo320 cells is primarily mediated by the over-
expression of the transporter P-glycoprotein, which pumps out
xenobiotics from the cells. Doxorubicin was applied as a
positive control, and CuCl2 was also tested for comparison. In
addition, cytotoxicity was measured in normal human embry-
onal lung fibroblast cells (MRC-5). The determined IC50 values
using 72 h incubation time are collected in Table 4. The stock
solutions of the compounds were prepared in a 90% (v/v)
DMSO/H2O mixture, and in the final samples the DMSO con-
tent was always lower than 1%.
STSC was found to be weakly cytotoxic in all tested cell lines,
while thn-TSC showed higher activity in the MCF-7 breast
cancer cell line. The estrone-conjugate was the most cytotoxic
against all cancer cells, and lower IC50 values were obtained in
Fig. 6 Time dependent changes of the UV-vis spectra of the
[Cu(estrone–TSCH2)] complex (25 mM) in the presence of 50 equiv.
GSH (1.25 mM) at pH 7.4 in 30% (v/v) DMSO/H2O under anaerobic
conditions and the inserted figure shows the absorbance values at
384 nm plotted against the time {T = 25 1C; I = 0.1 M (KCl)}.
Table 4 In vitro cytotoxicity (IC50 values in mM) of STSC, thn-TSC, estrone–TSC and their Cu(II) complexes in Colo205, Colo320, MCF-7 and MRC-5 cell
lines {72 h exposure}
IC50 (mM) Colo205 Colo320 MCF-7 MRC-5
STSC 65.3  2.2 56.6  2.2 45.2  3.2 72.4  4.8
thn-TSC 84.3  4.3 50.6  1.0 3.73  0.83 34.0  3.9
estrone–TSC 20.3  1.4 9.85  0.66 6.42  0.40 22.6  3.5
[Cu(STSCH2)] 0.99  0.09 0.90  0.05 0.31  0.01 1.20  0.09
[Cu(thn-TSCH2)] 0.61  0.03 0.60  0.04 0.26  0.02 0.48  0.02
[Cu(estrone–TSCH2)] 1.99  0.19 1.61  0.56 0.57  0.03 1.59  0.13
CuCl2 19.7  0.9 20.0  2.3 36.6  1.5 24.5  2.6
Doxorubicin 3.28  0.22 3.12  0.27 n.d. 5.19  0.21
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the multidrug resistant Colo320 and MCF-7 cells. Notably,
these compounds were found to be moderately toxic in the
normal fibroblast cells. Fairly low IC50 values (o0.3–2 mM) were
determined for the copper(II) complexes, which were much
more cytotoxic than the respective ligands, the copper(II) salt
and doxorubicin. Unfortunately, the complexes did not show
selectivity against the cancer cells compared to the normal cells.
Since the TSC compounds showed synergism with CuCl2,
and the cytotoxic activity of copper(II)–TSC complexes is often
associated with generation of reactive oxygen species,12,13,38,39
the compounds were further investigated regarding their intra-
cellular ROS production, catalase activity and their effect on
cellular GSH level. These assays were performed in MCF-7 and
the triple-negative SUM159 breast cancer cells; therefore cyto-
toxicity was also measured in these cell lines using 24 h
incubation time. In addition IC50 values were determined in
the HER2-positive SkBr3 breast cancer and the hepatocellular
carcinoma HepG2 cell lines. The in vitro cytotoxicity data in
these cells are shown in Table 5, which show a similar activity
trend of the tested compounds as it was observed in the
Colo205, Colo320, MCF-7 cells using 72 h exposure time;
however, the IC50 values are higher due to the shorter incuba-
tion period. Notably, estrone–TSC was more cytotoxic against
the tested breast cancer cells than the non-steroidal STSC and
thn-TSC suggesting that the steroidal carrier might have a role
in the cellular uptake, however the copper(II) complexes of the
three ligands did not show this difference in the activity. ROS
production was measured in MCF-7 and SUM159 cell lines
using the ROS sensitive cell permeable dye 2,7-dichloro-
dihydrofluorescein diacetate (DCFH-DA) in the presence and
absence of N-acetyl-cysteine (NAC) (Fig. 7 and Table S4, ESI†).
Results are expressed as fold change in the emission intensities
after exposure to the test compound relative to the solvent
control (without the use of NAC). The ligands and their
copper(II) complexes showed no or weak ability to produce
ROS under the applied conditions (1 mM concentration where
the compounds are non-cytotoxic, 60 min incubation time);
and the somewhat higher fold change of intensity was observed
only in the case of the copper(II) complexes in SUM159 cells and
for the complex of thn-TSC and estrone–TSC in MCF-7 cells.
Addition of the reducing agent NAC decreased the ROS produc-
tion in all cases of the compounds tested.
As a next step GSH level was measured in SUM159 cells
selected by the higher ROS production in the presence of the
copper(II) complexes. GSH level might have importance in
activity, as disturbance in GSH homeostasis is often involved
in cancer progression.40 Based on the data obtained for
the GSH levels (Fig. S12a, ESI†), it can be concluded that the
studied compounds decreased the GSH level compared to the
solvent control except the copper(II) complex of STSC, although
the increment was not significant. Catalase activity was also
measured in SUM159 cell lines to monitor the antioxidant
status of the cells (results are shown in Fig. S12b, ESI†).
Catalase is an antioxidant enzyme that converts H2O2 to H2O
and O2; therefore it is able to protect cells against H2O2 stress.
Table 5 In vitro cytotoxicity (IC50 values in mM) of STSC, thn-TSC, estrone–TSC and their Cu(II) complexes in SkBr3, SUM159 and HepG2 cell lines {24 h
exposure}
IC50 (mM) MCF-7 SkBr3 SUM159 HepG2
STSC 4100 450 4100 450
thn-TSC 4100 450 4100 450
estrone–TSC 31.4  0.4 19.3  0.6 54.8  2.6 450
[Cu(STSCH2)] 5.77  0.47 0.84  0.04 2.96  0.41 4.34  0.98
[Cu(thn-TSCH2)] 3.02  0.04 0.89  0.09 1.03  0.48 3.39  0.75
[Cu(estrone–TSCH2)] 11.5  1.1 3.28  0.39 4.27  0.47 6.59  0.16
CuCl2 4100 450 73.7  0.5 450
Fig. 7 Characterization of intracellular ROS production with DCFH-DA
assay in MCF-7 (a) and SUM159 (b) cells. ROS induction by 1 mM compound
was evaluated with or without 1 mM NAC. Fluorescence emission intensity
was measured following 60 min incubation with the indicated
compounds. Fold change in intensity represents the ratio of the measured
intensity to that of the solvent control (without NAC). Values show the
mean of three experiments (see data in Table S4, ESI†) {lEX = 500 nm;
lEM = 529 nm}.
NJC Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
1 
Ju
ly
 2
02
0.
 D
ow
nl
oa
de
d 
on
 9
/1
3/
20
20
 1
0:
12
:5
6 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This journal is©The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2020 New J. Chem., 2020, 44, 12154--12168 | 12163
The tested compounds showed similar and low catalase activity,
and an increased catalase activity was detected only for the
copper(II) complex of STSC.
On the whole, the studied copper(II) complexes are highly
and more cytotoxic against the tested cancer cell lines than the
ligands. They can be reduced by GSH with a similar reaction rate,
they showed a slightly elevated intracellular ROS production in
MCF-7 and SUM159 cell lines, but their effect on the catalase
activity and GSH level was minor.
Conclusions
Novel thiosemicarbazone derivatives were prepared through
molecular hybridization of salicylaldehye TSC (STSC) with
estrone and th-1-n, respectively, which yielded copper(II) com-
plexes with marked cytotoxic activity in various human cancer
cell lines. The introduction of the TSC moiety to the sterane
backbone resulting in estrone–TSC was performed via the
condensation reaction of 2-formyl-estrone, obtained from
estrone by ortho-formylation, and thiosemicarbazide in EtOH
under MW-irradiation. A simpler bicyclic derivative (thn-TSC)
was also prepared from th-1-n using a similar procedure.
Copper(II) complexes of both ligands and of STSC, for comparison,
were synthesized and characterized by ESI-MS, UV-vis and EPR
spectroscopy. The neutral ligand thn-TSC and the complex of
[Cu(thn-TSCH1)Cl] could be crystallized and the (O
,N,S)
coordination of the ligand to the copper ion in a square planar
geometry could be confirmed by single crystal X-ray diffraction.
Detailed solution equilibrium studies were performed to study
the proton dissociation processes of the ligands and their
complexation with copper(II) ions by spectrophotometric titra-
tions in a 30% DMSO/H2O solvent mixture due to their limited
water solubility. In addition, pKa values of the ligands attri-
buted to the deprotonation of the phenolic OH moiety were
determined by fluorometry in pure aqueous solutions. Notably,
somewhat higher pKa values were obtained for estrone–TSC
and thn-TSC compared with the reference compound STSC in
both media. Based on the pKa values, all three compounds are
present practically in their neutral forms (almost 100%) at
physiological pH. The estrone–TSC and thn-TSC conjugates
were found to be more lipophilic, showed higher effective
passive permeability coefficients, thus higher membrane
permeability based on the PAMPA assay compared to STSC.
Formation of three different types of copper(II) complexes
was identified in the DMSO/H2O medium according to the
spectro-photometric titrations in all cases. Namely, a proto-
nated complex is formed in the acidic pH range with (O,N,S)
donors containing the non-coordinating hydrazonic nitrogen
protonated. By the deprotonation of the latter moiety, the
ligand coordinates via an (O,N,S) donor set and the forming
complex predominates in a wide pH range (6–9) including the
physiological pH. This coordination mode was confirmed
by EPR spectroscopy in the isolated [Cu(thn-TSCH2)] and
[Cu(estrone–TSCH2)] complexes. With increasing pH a mixed
hydroxido species is formed with (O,N,S)(OH) coordination
mode. In spite of the similar stoichiometry of the complexes,
differences in their solution stability were observed giving the
following order: STSCo thn-TSCo estrone–TSC. Interestingly,
the isolated neutral complexes were found to be less lipophilic
possessing lower (but still high) permeability than the ligands.
The copper(II) complexes of estrone–TSC, thn-TSC and STSC
could be efficiently reduced with similar reaction rates by the
physiological reducing agent GSH under anaerobic conditions
accompanied by the release of the ligand, and could be oxidized
back by atmospheric oxygen reversibly.
Among the ligands estrone–TSC was the most cytotoxic
against the doxorubicin-sensitive Colo205 and the multidrug
resistant Colo320 human colonic adenocarcinoma cell lines.
Both novel ligands showed low micromolar IC50 values in the
hormone-responsive MCF-7 breast cancer cell lines (thn-TSC:
3.7 mM, estrone–TSC: 6.4 mM). The copper(II) complexes of
estrone–TSC, thn-TSC and STSC were significantly more cyto-
toxic than the ligands characterized by 1–2 orders of magnitude
lower IC50 values in all tested cancer cell lines (Colo205,
Colo320, MCF-7, SkBr3, SUM159 and HepG2), and complex of
thn-TSC exhibited the lowest IC50 values. Low intracellular ROS
production was observed for the copper(II) complexes in
SUM159 cells, but it was higher than obtained for the ligands
at 1 mM compound concentration. Meanwhile, somewhat lower
catalase activity and intracellular GSH level were found almost
in all cases (except the Cu–STSC complex). Based on the results,
the role of the redox properties of the copper(II) complexes in
the mechanism of action cannot be excluded, however, more
biological assays are needed to elucidate the exact mechanism
of action.
Experimental section
Chemicals and instruments used for the syntheses and
characterization
STSC, CuCl2, KCl, HCl, KOH, NaH2PO4, Na2HPO4, DMSO,
EDTA, GSH, ascorbic acid, MTT, NAC, DCFH-DA, 2,20-dinitro-
5,50-dithiodibenzoic acid (DTNB), 4-(2-hydroxyethyl)-1-piperazine-
ethanesulfonic acid (HEPES), 4,4-dimethyl-4-silapentane-1-sulfonic
acid (DSS) and doxorubicin were purchased from Sigma-Aldrich in
puriss quality. Milli Q water was used for sample preparation.
CuCl2 stock solution was made by the dissolution of anhydrous
CuCl2 in water and its exact concentration was determined by
complexometry through the EDTA complex. The stock solution of
STSC, thn-TSC and estrone–TSC was prepared on a weight-in-
volume basis dissolved in DMSO.
Reagents and materials used for the synthesis were pur-
chased from commercial suppliers (TCI, Tokyo, Japan; Alfa
Aesar, Haverhill, MA, USA and Sigma-Aldrich Corporation, St.
Louis, MO, USA). All solvents were dried and purified according
to standard procedures.
MW-assisted reactions were carried out with a CEM Discover
SP instrument (CEM Corporation, Matthews, NC, USA) using
a maximum power of 200 W with dynamic control program.
Thin layer chromatography was carried out on Kieselgel-G
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(Si 254 F, Merck KGaA, Darmstadt, Germany) plates (0.25 mm
thick). The spots were detected by spraying with phospho-
molybdic acid (5%) in aqueous phosphoric acid (50%) or
visualized by UV light (254 nm). The products were purified
by preparative column chromatography on Merck silica gel 60,
40–63 mm (Merck KGaA, Darmstadt, Germany). Melting points
(Mps) were measured on an SRS Optimelt digital device (Stan-
ford Research Systems Inc, Sunnyvale, CA, USA). NMR spectra
were recorded at 298 K with a Bruker Avance III HD Ascend 500
Plus instrument. Chemical shifts are reported in ppm (d scale)
and coupling constants (J) in Hz. The 1H resonance signals are
indicated as a singlet (s), a broad singlet (bs), a doublet (d), a
double doublet (dd), a triplet (t) or a multiplet (m). The
13C NMR spectra are 1H-decoupled. The J-MOD pulse sequence
was applied to determine multiplicities.
Synthesis of thn-TSC and estrone–TSC
ortho-Formylation of phenols (general synthetic method).
Phenol derivative (estrone, 5,6,7,8-tetrahydronaphthalen-2-ol
(th-2-n) or 5,6,7,8-tetrahydronaphthalen-1-ol (th-1-n), 2.0 mmol)
was suspended in dry THF (30 mL) and anhydrous MgCl2
(3 equiv.), triethylamine (TEA) (3 equiv.) and paraformaldehyde
(PFA) (4 equiv.) were added. The suspension was kept at reflux
temperature for 4 h under N2 atmosphere. The mixture was
then cooled to room temperature, neutralized with diluted HCl
(1 M), then extracted with ethyl acetate (EtOAc) (3  30 mL).
The combined organic phase was dried over anhydrous Na2SO4,
and evaporated. The crude product was purified by flash
chromatography.
Synthesis of 2-formyl-estrone (1). According to the general
synthetic method, estrone (541 mg) was used as phenolic
compound. After separation of the crude product containing
both the 2-formyl- (1) and 4-formyl regioisomers (2) of estrone
with CH2Cl2 as eluent, EtOAc/hexane (30 : 70 v/v%) was used for
further purification to give 1 as a white solid (255 mg, 43%), Mp
160–162 1C (164–165 1C34); 1H NMR (DMSO-d6, 500 MHz): d
(ppm) 0.92 (s, 3H, 18-H3), 1.33–1.60 (overlapping m, 6H), 1.77
(m, 1H), 1.95 (m, 2H), 2.07 (m, 1H), 2.08 (m, 1H), 2.35 (m, 1H),
2.44 (m, 1H), 2.85 (m, 2H, 6-H2), 6.70 (s, 1H, 4-H), 7.57 (s, 1H, 1-
H), 10.14 (s, 1H, CHO), 10.45 (bs, 1H, OH); 13C NMR (DMSO-d6,
125 MHz): d (ppm) 13.4 (C-18), 21.1 (CH2), 25.3 (CH2), 25.6
(CH2), 29.3 (CH2), 31.2 (CH2), 35.3 (CH2), 37.4 (CH), 42.9 (CH),
47.3 (C-13), 49.5 (CH), 116.6 (C-4), 120.2 (C-2), 126.4 (C-1), 131.4
(C-10), 146.6 (C-5), 158.5 (C-3), 192.0 (CHO), 219.4 (C-17).
Synthesis of 3-hydroxy-5,6,7,8-tetrahydronaphthalene-2-carb-
aldehyde (3) and 2-hydroxy-5,6,7,8-tetrahydronaphthalene-1-
carbaldehyde (4). According to the general synthetic method,
th-2-n (296 mg) was used as phenolic compound. Repeated
chromatographic purification using different eluents failed,
and a 5 : 4 regioisomeric mixture of 3 and 4 was obtained as a
yellowish oil (311 mg, 88%). The two products were assigned
based on the NMR spectra recorded for the mixture.
Compound 3. 1H NMR (DMSO-d6, 500 MHz): d (ppm) 1.69
(overlapping m, 4H, 5-H2 and 6-H2), 2.63 (m, 2H, 4-H2), 2.70
(m, 2H, 7-H2), 6.67 (s, 1H, 8-H), 7.35 (s, 1H, 3-H), 10.13
(s, 1H, CHO); 13C NMR (DMSO-d6, 125 MHz): d (ppm) 22.3
and 22.7 (C-6 and C-7), 27.7 (C-5), 29.4 (C-8), 116.6 (C-1), 120.4
(C-4a), 128.0 (C-3), 129.6 (C-4), 146.6 (C-8a), 158.2 (C-1),
191.7 (CHO).
Compound 4. 1H NMR (DMSO-d6, 500 MHz): d (ppm) 1.69
(overlapping m, 4H, 4-H2 and 5-H2), 2.64 (m, 2H, 6-H2), 3.06
(t, 2H, J = 6.1 Hz, 3-H2), 6.74 (d, 1H, J = 8.5 Hz, 8-H), 7.24 (d, 1H,
J = 8.5 Hz, 7-H), 10.38 (s, 1H, CHO); 13C NMR (DMSO-d6, 125
MHz): d (ppm) 22.0 (C-7), 22.3 (C-6), 25.3 (C-8), 28.5 (C-5), 114.7
(C-3), 118.4 (C-1), 127.9 (C-4a), 138.0 (C-4), 139.7 (C-8a), 160.6
(C-2), 195.3 (CHO).
Synthesis of 1-hydroxy-5,6,7,8-tetrahydronaphtalene-2-
carbaldehyde (5). According to the general synthetic method,
th-1-n (296 mg) was used as phenolic compound. After purifica-
tion with hexane/CH2Cl2 (80 : 20 v/v%) as eluents, 5 was
obtained as a colorless oil (276 mg, 78%) (Mp: 29–30 1C41);
1H NMR (DMSO-d6, 500 MHz): d (ppm) 1.73 (overlapping m, 4H,
6-H2 and 7-H2), 2.58 (t, 2H, J = 6.1 Hz) and 2,75 (t, 2H, J =
5.9 Hz): 6-H2 and 7-H2, 6.80 (d, 1H, J = 8.0 Hz, 4-H), 7.48 (d, 1H,
J = 8.0 Hz, 3-H), 9.92 (s, 1H, CHO), 11.23 (bs, 1H, OH); 13C NMR
(DMSO-d6, 125 MHz): d (ppm) 21.7 and 21.9 (2C): C-6, C-7 and
C-8, 29.8 (C-5), 118.1 (C-2), 120.8 (C-4), 124.9 (C-8a), 129.8 (C-3),
147.1 (C-4a), 158.8 (C-1), 196.7 (CHO).
Synthesis of TSC derivatives (general synthetic method).
Carbaldehyde (1 or 5, 0.5 mmol) was suspended in abs. EtOH
(5 mL), then thiosemicarbazide (55 mg, 0.6 mmol) was added in
the presence of a few drops of acetic acid. The mixture was
irradiated at 80 1C for 5 min, and then poured into cold water.
The precipitate obtained was filtered in vacuo, washed with cold
water and dried. The crude product was purified by column
chromatography.
Synthesis of 2-((3-hydroxy-estra-1,3,5(10)-triene-2-yl)methylene)-
hydrazine-1-carbothioamide (estrone–TSC). According to the
general synthetic method, 2-formyl-estrone (1, 149 mg) and
thiosemicarbazide were used. After purification with EtOAc/
CH2Cl2 using gradient elution (10 : 90- 20 : 80 v/v%), estrone–
TSC was obtained as a white solid (175 mg, 94%), Mp4200 1C
(decomp.); 1H NMR (DMSO-d6, 500 MHz): d (ppm) 0.83 (s, 3H,
18-H3), 1.28–1.59 (overlapping m, 6H), 1.77 (m, 1H), 1.93
(m, 2H), 2.07 (m, 1H), 2.14 (m, 1H), 2.43 (m, 1H), 2.56
(m, 1H), 2.77 (m, 2H, 6-H2), 6.56 (s, 1H, 4-H), 7.72 (s, 1H,
1-H), 7.93 (s, 1H, one H of NH2), 8.05 (s, 1H, the other H of
NH2), 8.32 (s, 1H, CHQN), 9.55 (s, 1H, OH), 11.26 (s, 1H, NH);
13C NMR (DMSO-d6, 125 MHz): d (ppm) 13.6 (C-18), 21.1 (CH2),
25.3 (CH2), 25.9 (CH2), 29.1 (CH2), 31.4 (CH2), 35.4 (CH2), 37.9
(CH), 43.6 (CH), 47.3 (C-13), 49.6 (CH), 115.6 (C-4), 117.8 (C-2),
123.3 (C-1), 130.9 (C-10), 140.0 (C-5), 140.3 (CHQN), 154.3 (C-3),
177.3 (CQS), 219.7 (C-17).
Synthesis of 2-((1-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)-
methylene)hydrazine-1-carbothioamide (thn-TSC). According
to the general synthetic method, 1-hydroxy-5,6,7,8-tetrahydro-
naphtalene-2-carbaldehyde (5, 88 mg) and thiosemicarbazide
were used. After purification using gradient elution (CH2Cl2/EtOAc
(20 : 80 v/v%),- EtOAc), thn-TSC was obtained as a yellowish solid
(90 mg, 72%), Mp 238–240 1C; 1H NMR (DMSO-d6, 500 MHz):
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d (ppm) 1.72 (overlapping m, 4H, 6-H2 and 7-H2), 2.59 (t, 2H, J =
6.1 Hz) and 2.68 (t, 2H, J = 5.9 Hz): 6-H2 and 7-H2, 6.35 (bs, 2H,
NH2), 6.61 (d, 1H, J = 7.9 Hz, 4-H), 7.10 (d, 1H, J = 7.9 Hz, 3-H), 8.03
(s, 1H, CHQN), 10.15 (s, 1H, NH), 10.31 (bs, 1H, OH); 13C NMR
(DMSO-d6, 125 MHz): d (ppm) 22.3 (2C) and 22.6: C-6, C-7 and C-8,
29.3 (C-5), 115.7 (C-2), 120.1 (C-4), 124.2 (C-8a), 126.3 (C-3), 139.6
(C-4a), 142.9 (CHQN), 154.1 (CQO), 155.9 (C-1).
Synthesis and characterization Cu(II) complexes of thn-TSC,
estrone–TSC and STSC. The ligand STSC (0.054 mmol), thn-TSC
(0.054 mmol) and estrone–TSC (0.054 mmol) were dissolved in
DMSO (10.8 mL), then 2.23 mL CuCl2 aqueous solution
(0.054 mmol) was added, and the pH was adjusted to pH B
7.4 by the addition of 10 mM HEPES (10 mL). Pale brownish
precipitate was formed. The precipitate was decanted, washed
with 5–5 mL water four times and dried at 50 1C overnight.
Under the preparation conditions the complexes contain the
ligands in the completely deprotonated forms with (O,N,S)
donor set, and were characterized by ESI-MS, EPR spectroscopy
and UV-vis spectrophotometry.
ESI-MS measurements were performed using a Waters
Q-TOF Premier (Micromass MS Technologies, Manchester,
UK) mass spectrometer equipped with electrospray ion source.
Samples contained 20–50 mM complex dissolved in methanol
containing 0.5% (v/v) acetic acid in the case of the estron-TSC
complex (see spectra in Fig. S13, ESI†).
UV-vis spectra on an Agilent Carry 8454 spectrophotometer
were also recorded for the complexes and ligands in methanol
and in n-octanol for the sake of comparison.
EPR spectra for the copper(II) complexes were recorded with
a BRUKER EleXsys E500 spectrometer (microwave frequency
9.54 GHz, microwave power 13 mW, modulation amplitude
5 G, modulation frequency 100 kHz). Powder of the copper(II)
complexes was dissolved in pure DMSO to obtain 3 mM
concentration solutions. The room temperature EPR spectra
were recorded in capillaries applying 12 scans. For the frozen
solution spectra 0.10 mL samples were diluted with 0.10 mL
water and transferred into EPR tubes and the spectra were
recorded in Dewar containing liquid nitrogen (77 K). The room
temperature spectra were corrected by subtracting the back-
ground spectrum of pure DMSO. The spectra were simulated
by the ‘‘EPR’’ program42 using the parameters go, Ao copper
hyperfine (ICu = 3/2) coupling and four linewidth parameters.
The anisotropic EPR spectra were analyzed with the same
program. Rhombic g-tensor (gx, gy, gz) and copper hyperfine
tensor (ACux , A
Cu
y , A
Cu
z ) have been used. The nitrogen super-
hyperfine structure was taken into account with a rhombic
hyperfine tensor (aNx , a
N
y , a
N
z ) were the xyz directions referred to
the g-tensor orientations. Orientation dependent linewidth
parameters (a, b, and g) were used to fit the linewidths
through the equation sMI = a + bMI + gMI
2, where MI denotes
the magnetic quantum number of copper(II) ion. Since a
natural CuCl2 was used for the measurements, all spectra
were calculated by the summation of spectra 63Cu and
65Cu weighted by their natural abundances. The hyperfine
and superhyperfine coupling constants and the relaxation
parameters were obtained in field units (Gauss = 104 T).
The results of the EPR spectroscopic measurements are
detailed in the Results.
Characterization of the complexes. Complex [Cu(estrone–
TSCH2)]: yield: 61%; ESI-MS (methanol, positive): m/z 433.0883
[M + 1]+, 433.0891 calcd for C20H24CuN3O2S; lmax in methanol:
318, 328, 392 nm; in n-octanol: 318, 328, 394 nm.
Complex [Cu(thn-TSCH2)]: yield: 45%; ESI-MS (methanol,
positive): m/z 311.0156 [M + 1]+, 311.0154 calcd for C12H14CuN3OS;
lmax in methanol: 305, 396 nm; in n-octanol: 318, 328, 396 nm.
Complex [Cu(STSCH2)]: yield: 38%; ESI-MS (methanol,
positive): m/z 256.9682 [M + 1]+, 256.9684 calcd for C8H8CuN3OS;
lmax in methanol: 269, 321, 386 (broad band) nm; in n-octanol:
324, 388 (broad band) nm.
Solution equilibrium studies: UV-visible spectrophotometric
and fluorometric titrations
An Orion 710A pH-meter equipped with a Metrohm combined
electrode (type 6.0234.100) and a Metrohm 665 Dosimat burette
were used for the UV-vis and fluorometric titrations at 25.0 
0.1 1C. Ionic strength of 0.10 M (KCl) was used in order to keep
the activity coefficients constant. The titrations were performed
with carbonate-free KOH solution of known concentration
(0.10 M) with or without 30% (v/v) DMSO content. The electrode
system was calibrated to the pH = log[H+] scale by means of
blank titrations (HCl vs. KOH) according to the method sug-
gested by Irving et al.43 The average water ionization constant
(pKw) is 13.76  0.05 in water and 14.52  0.05 in the 30% (v/v)
DMSO/H2O mixture. Argon was always passed over the solu-
tions during the titrations.
An Agilent Cary 8454 diode array spectrophotometer was
used to record the UV-vis spectra at an interval of 200–800 nm.
The path length was 1 cm. Spectrophotometric titrations were
performed in a 30% (v/v) DMSO/H2O mixture on samples
containing the ligands at 50–70 mM concentration, in the pH
range from 1.0 to 12.5 in the absence or in the presence of 1 or
0.5 equiv. copper(II) ions. The fluorescence spectra were
recorded for TSC ligands on a Hitachi-4500 spectrofluorometer
using a 1 cm quartz cell. The fluorometric titrations were
performed on samples containing the ligands at 1 mM concen-
tration in the pH range from 5 to 11.5 titrated by KOH solution
in pure aqueous solution.
Proton dissociation constants (Ka) of the TSC ligands, the
overall stability constants (b) of the copper(II) complexes and
the UV-vis and/or emission spectra of the individual species
were calculated by the computer program PSEQUAD44 as it was
done in our previous works.14,45
Solution kinetic studies on the reduction of the copper(II)
complexes
The redox reaction of the copper(II) complexes with GSH and
ascorbic acid was studied at 25.0  0.1 1C on a Hewlett Packard
8452A diode array spectrophotometer using a special, tightly
closed tandem cuvette (Hellma Tandem Cell, 238-QS). The reac-
tants were separated until the reaction was triggered. Both isolated
pockets of the cuvette were completely deoxygenated by bubbling a
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stream of argon for 10–10min before mixing the reactants. Spectra
were recorded before and then immediately after the mixing, and
changes were followed till no further absorbance change was
observed. One of the isolated pockets contained the reducing
agent (GSH or ascorbic acid), while the other contained the
copper(II) complex, and their final concentrations were 1250 mM
and 25 mM, respectively after mixing. The pH of all the solutions
was adjusted to 7.40 by 100 mM HEPES buffer and an ionic
strength of 0.1 M (KCl) was applied. The stock solutions of the
reducing agents and the complexes were freshly prepared
every day.
During the calculations the absorbance (A)–time (t) curves
were fitted and analyzed at the lmax of the complex. (A0 Afinal)
e(at) + Afinal equation was used where A0, Afinal and a parameters
were refined and accepted at the minimal value of the weighted
sum of squared residuals (difference between the measured and
calculated absorbance values) at the given wavelength. Then
observed rate constants (kobs) of the redox reaction were obtained
from the data points of the simulated absorbance–time curves as
the slope of the ln(A/A0) vs. time plots.
Crystallographic structure determination of compounds
thn-TSC (I) and [Cu(thn-TSCH1)Cl] (II)
Single crystals suitable for X-ray diffraction experiment of
compound thn-TSC (I) were grown from warmed and then
slowly evaporated acetone at room temperature. For the crystal-
lization of its complex thn-TSC (0.027 mmol) was dissolved in
methanol (5.4 mL), then 1.11 mL CuCl2 in an aqueous solution
(0.027 mmol) was added. The reaction mixture was stirred at
65 1C during 2 h and after filtered, and the solvent was
concentrated under reduced pressure to 2 ml. Then the crystal
of copper complex [Cu(thn-TSCH1)Cl] (II) was obtained
through slow evaporation from concentrated methanol–water
solution at room temperature. Single crystals were mounted on
loops and transferred to the goniometer. X-ray diffraction
data were collected at 165(5) K on a Rigaku RAXIS-RAPID II
diffractometer using Cu-Ka radiation. Numerical absorption
correction46 was carried out using the program CrystalClear,47
SHELX48 program package under WinGX49 or Olex250 softwares
were used for structure solution and refinement. The structures
were solved by direct methods. The models were refined by
full-matrix least squares on F2. Refinement of non-hydrogen
atoms was carried out with anisotropic temperature factors. For
crystal thn-TSC (I) two carbon atoms C7 and C8 was found in
disordered positions. The two positions were denoted by ‘A’
and ‘B’ and the occupancy ratio between them was 68% and
32%, respectively. For crystal [Cu(thn-TSCH1)Cl] (II) small size
and platelet shape crystal prevented the collection of high
resolution data which resulted in a higher Rint and final R1
and wR2 values. In the refinement process restrains have been
used for the ring carbon atoms. In both structures, hydrogen
atoms were placed into geometric positions. They were included
in structure factor calculations but they were not refined. The
isotropic displacement parameters of the hydrogen atoms were
approximated from the U(eq) value of the atom they were bonded
to. The summary of data collection and refinement parameters
are collected in Table S1 (ESI†). Selected bond lengths and angles
of compounds were calculated by PLATON software.51 The
graphical representation and the edition of CIF files were done by
Mercury52 and PublCif53 softwares. The crystallographic data files
for the complexes have been deposited with the Cambridge
Crystallographic Database as CCDC 1986236 and 1986237.†
Lipophilicity and artificial membrane permeability assays
Distribution coefficient (D7.4) values of ligands and the com-
plexes were determined (or attempted to be determined) by the
traditional shake-flask method in n-octanol/buffered aqueous
solution at pH 7.40 (20 mM phosphate buffered saline (PBS))
at 25.0  0.2 1C as described previously.54 Additionally, log P
values were estimated for the ligands by the means of the
MarvinSketch software.35
Parallel artificial membrane permeability assay (PAMPA)
was applied for the ligands and complexes with a Corning
Gentest pre-coated PAMPA Plate System.55 In summary, the
96-well filter plate was used as the permeation acceptor and the
96-well bottom plate was used as the permeation donor. For
simplicity, PBS (containing 4% (v/v) DMSO) was used both as
donor and acceptor buffer throughout this study. The initial
donor solutions were prepared by diluting DMSO stock
solutions (500 mM) in PBS (25-fold dilution). Donor plate was
filled with 300 mL of the donor solutions (containing the test
compounds). Each well of the filter plate contained 200 mL
buffer as acceptor phase. The resulting ‘sandwich’ was pro-
tected with parafilm to prevent evaporation and incubated at
room temperature at 25 1C for 5 h. Then, solutions from the
donor and acceptor wells were transferred to Eppendorf tubes
and their UV-vis spectra were recorded to determine the
concentration of the components. Peff values were calculated
according to the equation reported by Yu et al.56
In vitro cell studies
Cell lines and culture conditions. All cell culture reagents
were obtained from Sigma-Aldrich and plastic ware from
Sarstedt (Germany). Human colonic Colo 205 doxorubicin-
sensitive and Colo 320/MDR-LRP multidrug resistant adeno-
carcinoma cell lines were purchased from LGC Promochem,
Teddington, UK. In addition, hepatocellular carcinoma cell line
(HepG2) and three subtypes of breast cancer cell lines: the
hormone-responsive MCF-7, the HER2-positive SkBr3 and the
triple-negative SUM159 cancer cell lines were also used. MRC-5
human embryonal lung fibroblast cell line was purchased from
LGC Promochem, Teddington, UK. The cells were cultured in
Roswell Park Memorial Institute (RPMI) 1640 medium for Colo
and MRC-5 or in Dulbecco’s modified Eagle’s medium (DMEM)
for HepG2 and breast cancer cell lines supplemented with 10%
heat-inactivated fetal bovine serum, 2 mM L-glutamine, 1 mM
sodium pyruvate and 100 mMHEPES. The cells were incubated at
37 1C, in a 5% CO2, 95% air atmosphere. All cell lines were
detached with trypsin–versene (EDTA) solution for 5 min at 37 1C.
MTT and EZ4U assays. The tested compounds were dis-
solved in a 90% (v/v) DMSO/H2O using 10 mM concentration.
The metal salts without ligands were also tested. Doxorubicin
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(Merck) was used as a positive control. Then stock solutions
were diluted in complete culture medium, and two-fold serial
dilutions of compounds were prepared in 100 mL of RPMI 1640,
horizontally. The semi-adherent colonic adenocarcinoma cells
were treated with trypsin–versene (EDTA) solution. They were
adjusted to a density of 1  104 cells in 100 mL of RPMI 1640
medium, and were added to each well, with the exception of the
medium control wells. The final volume of the wells containing
compounds and cells was 200 mL. The culture plates (Colo205,
Colo320, MCF-7, MRC-5) were incubated at 37 1C for 72 h; at the
end of the incubation period, 20 mL of MTT solution (from a
stock solution of 5 mg mL1) were added to each well. After
incubation at 37 1C for 4 h, 100 mL of SDS solution (10% in
0.01 M HCI) were added to each well and the plates were further
incubated at 37 1C overnight. The EZ4U assay kit (Biomedica,
Wien, Austria) was used according to manufacturer’s instruc-
tions in the case of cell lines MCF-7, HepG2, SkBr3 and
SUM159. Samples and cells were prepared in the similar way
as in the case of the traditional MTT assay. The compounds
were diluted in a volume of 100 mL medium, then the culture
plates were incubated at 37 1C for 24 h; at the end of the
incubation period, 20 mL of MTT solution was added to each
well and incubated for 2 h. The cell growth was determined
using both methods by measuring the optical density (OD) at
450 nm (ref. 620 nm) with a Multiscan EX ELISA reader.
Inhibition of the cell growth (expressed as IC50: inhibitory
concentration that reduces by 50% the growth of the cells
exposed to the tested compounds) was determined from the
sigmoid curve where 100  ((ODsample  ODmediumcontrol)/
(ODcell control  ODmediumcontrol))  100 values were plotted
against the logarithm of compound concentrations. Curves
were fitted by GraphPad Prism software57 using the sigmoidal
dose–response model (comparing variable and fixed slopes).
The IC50 values were obtained from at least 3 independent
experiments.
ROS production measurement was performed in MCF-7 and
SUM159 cell lines with DCFH-DA. The emission intensity of the
fluorescent 2,7-dichlorofluorescein (DCF) was measured at
529 nm using 500 nm excitation wavelength. The human cancer
cells were seeded 1  104 in 100 mL DMEM/10% fetal bovine
serum (FBS) into in 96-well microtiter plates. After allowing
cells to adhere for 24 h, 1 mM NAC was added to some wells
while 100 mM DCFH-DA was added to all wells. After removing
the media with the excess of DCFH-DA, cells were treated with
the compounds in 1 mM concentration (where the compounds
are not toxic to the cells). The increase in ROS caused by
compounds applied was measured at different time points –
prior to treatment and 60 min after the treatment.
For the catalase activity and GSH level assays cells were
prepared in a same manner. The SUM159 cells were seeded in
6-well plates at density of 5 105 cell per well, and were allowed
24 h to attach to the well. Then, cells were treated with 1 mM
compound and left for 24 h after which they were harvested,
and the dry pellet was stored at 80 1C until analysis. For
analyses, cells were lysed in PBS by 4 freeze–thaw cycles, and
total protein content was measured by Bradford method.58
Total GSH was measured spectro-photometrically at 450 nm by
modified Tietze method based on reduction of DTNB (Ellman’s
reagent) to 2-nitro-5-thiobenzoate (TNB anion) by GSH.59 Catalase
activity was assayed by measuring H2O2 decomposition by
catalase in the whole cell lysate by Go´th method.60
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